Calyxt spun out from its parent company Cellectis to price an oversubscribed IPO at the bottom of the price range, while analysts remain concerned about gene editing regulation.
Gene editing was a key topic discussed at this week’s World Agri-Tech Innovation Summit in San Francisco.
Benson Hill Biosystems has identified a more precise and efficient gene-editing tool than CRISPR Cas-9 that uses a suite of new nucleases instead of the Cas-9 enzyme, according to Matt Crisp, CEO.
It was a busy week for agtech startups with new partnerships and awards, while regulations around gene-editing make slow progress.
We are very proud of the coverage we've given the food and agriculture technology market over the year, but there are always, of course, stories in other publications that we wish we'd written!
Feeling reflective as we approach the holiday season and the end of 2016? In this week’s podcast, we talk to two food and agtech experts about the trends they’ve noticed in ag and foodtech in 2016.
Two key features of the conference this year were a panel discussion about gene editing and the issue of public acceptance and innovating around food waste.
Kevin Zussman writes about the similarities of the crop protection and animal health industries, and how new technologies are disrupting these markets.
CRISPR has been lauded as the cheapest, fastest, and most precise gene-editing tool on the market, and it's not subjected to the tainted GMO label, but for how much longer?
Monsanto's CRISPR license comes with restrictions.
The gene-editing powerhouse the merger between Bayer and Monsanto could produce has been less discussed in media and investment circles, but is a major part of the transaction, writes Emma Cowan.